Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone

References

• Abelson JL. 1995. Cholecystokinin in psychiatric research: a time for cautious excitement. J Psychiatr Res 29:389–396.
   PubMed Web of Science ®Google Scholar
• Abelson JL, Young EA. 2003. Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition. Psychoneuroendocrinology 28: 169–180.
   PubMed Web of Science ®Google Scholar
• Abelson JL, Nesse RM, Vinik AI. 1994. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol Psychiatry 36:84–96.
   PubMed Web of Science ®Google Scholar
• Bradbury MJ, Akana SF, Cascio CS, Levin N, Jacobson L, Dallman MF. 1991. Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J Steroid Biochem Mol Biol 40:133–142.
   PubMed Web of Science ®Google Scholar
• Bradwejn J, Koszycki D. 2001. Cholecystokinin and panic disorder: past and future clinical research strategies. Scand J Clin Lab Invest Suppl 234:19–27.
   PubMedGoogle Scholar
• Bradwejn J, Koszycki D, Bourin M. 1991. Dose ranging study of the effects of cholecystokinin in healthy volunteers. J Psychiatry Neurosci 16:91–95.
   PubMed Web of Science ®Google Scholar
• Carter DA, Lightman SL. 1987. A role for the area postrema in mediating cholecystokinin-stimulated oxytocin secretion. Brain Res 435:327–330.
   PubMed Web of Science ®Google Scholar
• Chandra R, Liddle RA. 2007. Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14:63–67.
   PubMedGoogle Scholar
• Chen DY, Deutsch JA, Gonzalez MF, Gu Y. 1993. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718. Neurosci Lett 149:91–94.
   PubMed Web of Science ®Google Scholar
• Dallman MF, Akana SF, Levin N, Walker CD, Bradbury MJ, Suemaru S, . 1994. Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann NY Acad Sci 746:22–31.
   PubMed Web of Science ®Google Scholar
• de Kloet ER. 1997. Why Dexamethasone Poorly Penetrates in Brain. Stress 2:13–20.
   PubMedGoogle Scholar
• de Kloet ER, van der Vies J, de Wied D. 1974. The site of the suppressive action of dexamethasone on pituitary-adrenal activity. Endocrinology 94:61–73.
   PubMed Web of Science ®Google Scholar
• de Kloet ER, Joels M, Holsboer F. 2005. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463–475.
   PubMed Web of Science ®Google Scholar
• De Montigny C. 1989. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. Arch Gen Psychiatry 46:511–517.
   PubMed Web of Science ®Google Scholar
• Dillon DJ, Gorman JM, Liebowitz MR, Fyer AJ, Klein DF. 1987. Measurement of lactate-induced panic and anxiety. Psychiatry Res 20:97–105.
   PubMed Web of Science ®Google Scholar
• Dunn JD, Orr SE. 1984. Differential plasma corticosterone responses to hippocampal stimulation. Exp Brain Res 54:1–6.
   PubMed Web of Science ®Google Scholar
• Fink H, Rex A, Voits M, Voigt JP. 1998. Major biological actions of CCK. A critical evaluation of research findings. Exp Brain Res 123:77–83.
   PubMed Web of Science ®Google Scholar
• Jacobson L, Sapolsky R. 1991. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12:118–134.
   PubMed Web of Science ®Google Scholar
• Kajantie E, Phillips DI. 2006. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 31:151–178.
   PubMed Web of Science ®Google Scholar
• Kamilaris TC, Johnson EO, Calogero AE, Kalogeras KT, Bernardini R, Chrousos GP, . 1992. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone. Endocrinology 130:1764–1774.
   PubMed Web of Science ®Google Scholar
• Karssen AM, Meijer OC, Berry A, Sanjuan PR, de Kloet ER. 2005. Low doses of dexamethasone can produce a hypocorticosteroid state in the brain. Endocrinology 146:5587–5595.
   PubMed Web of Science ®Google Scholar
• Kellner M, Yassouridis A, Jahn H, Wiedemann K. 1997. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder. Psychopharmacology (Berlin) 133:55–61.
   PubMed Web of Science ®Google Scholar
• Kellner M, Yassouridis A, Hua Y, Wendrich M, Jahn H, Wiedemann K. 2002. Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men. J Psychiatr Res 36:1–6.
   PubMed Web of Science ®Google Scholar
• Lathe R. 2001. Hormones and the hippocampus. J Endocrinol 169:205–231.
   PubMed Web of Science ®Google Scholar
• Lindefors N, Linden A, Brene S, Sedvall G, Persson H. 1993. CCK peptides and mRNA in the human brain. Prog Neurobiol 40:671–690.
   PubMed Web of Science ®Google Scholar
• Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER. 1998. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789–1793.
   PubMed Web of Science ®Google Scholar
• Noble F, Roques BP. 1999. CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology. Prog Neurobiol 58:349–379.
   PubMed Web of Science ®Google Scholar
• Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K. 2006. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. Depress Anxiety 23:139–144.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Krey LC, McEwen BS. 1984. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA 81:6174–6177.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Armanini MP, Packan DR, Sutton SW, Plotsky PM. 1990. Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites. Neuroendocrinology 51:328–336.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Zola-Morgan S, Squire LR. 1991. Inhibition of glucocorticoid secretion by the hippocampal formation in the primate. J Neurosci 11:3695–3704.
   PubMed Web of Science ®Google Scholar
• Schmidt MV, Levine S, Oitzl MS, van der Mark M, Muller MB, Holsboer F, . 2005. Glucocorticoid receptor blockade disinhibits pituitary-adrenal activity during the stress hyporesponsive period of the mouse. Endocrinology 146: 1458–1464.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, . 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Clin Psychiatry 59(Suppl 20):22–33.
   PubMed Web of Science ®Google Scholar
• Wiedemann K, Holsboer F. 1990. The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST. J Affect Disord 19:133–137.
   PubMed Web of Science ®Google Scholar
• Wiedemann K, Lauer C, Pollmacher T, Holsboer F. 1994. Sleep endocrine effects of antigluco- and antimineralocorticoids in healthy males. Am J Physiol 267:E109–E114.
   PubMed Web of Science ®Google Scholar
• Wiedemann K, Jahn H, Yassouridis A, Kellner M. 2001. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Arch Gen Psychiatry 58:371–377.
   PubMed Web of Science ®Google Scholar
• Zwanzger P, Eser D, Nothdurfter C, Baghai TC, Moller HJ, Padberg F, . 2009. Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder. Pharmacopsychiatry 42:266–269.
   PubMed Web of Science ®Google Scholar